Effects of repeated-dose isradipine on the abuse liability of cocaine

Experimental and Clinical Psychopharmacology

Volumn 13, Issue 4, 2005, Pages 319-326

  Roache, John D ^a,b   Johnson, Bankole A ^a,b,c   Ait Daoud, Nassima ^a,b,c   Mauldin, James B ^a,b,d   Thornton, Joe E ^a,b,e   Wells, Lynda T ^a,b,c   Murff, William L ^a,b  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^b Mays Cancer Center at UT Health San Antonio   (United States)

^c UNIVERSITY OF VIRGINIA   (United States)

^d Department of Psychiatry   (United States)

^e North Florida Evaluation and Treatment Center   (United States)

Author keywords

Calcium channel antagonist; Cocaine; Drug abuse; Isradipine; Treatment

Indexed keywords

COCAINE; ISRADIPINE; PLACEBO;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; COCAINE DEPENDENCE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG FORMULATION; EUPHORIA; FEMALE; HEADACHE; HEART PALPITATION; HUMAN; IMMEDIATE RELEASE FORMULATION; INFUSION; MALE; MOOD; REINFORCEMENT; SUSTAINED RELEASE PREPARATION; TREATMENT OUTCOME;

ACETAMINOPHEN; ADMINISTRATION, ORAL; ADULT; ANALYSIS OF VARIANCE; ARRHYTHMIA; CALCIUM CHANNEL BLOCKERS; COCAINE; COCAINE-RELATED DISORDERS; CROSS-OVER STUDIES; DELAYED-ACTION PREPARATIONS; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; EMOTIONS; EUPHORIA; FEMALE; HEADACHE; HEART RATE; HUMANS; INFUSIONS, INTRAVENOUS; ISRADIPINE; MALE; MIDDLE AGED; NAUSEA; TABLETS; TREATMENT OUTCOME;

EID: 29444446425     PISSN: 10641297     EISSN: None     Source Type: Journal    
DOI: 10.1037/1064-1297.13.4.319     Document Type: Article

References (30)

1. Berridge, K. C., & Robinson, T. E. (1998). What is the role of dopamine in reward: Hedonic impact, reward learning, or incentive salience? Brain Research Reviews, 28, 309-369.
2. Bourson, A., Gower, A. J., Mir, A. K., & Moser, P. C. (1989). The effects of dihydropyridine compounds in behavioural tests of dopaminergic activity. British Journal of Pharmacology, 98, 1312-1318.
3. Calcagnetti, D. J., Keck, B. J., Quatrella, L. A., & Schechter, M. D. (1995). Blockade of cocaine-induced conditioned place preference: Relevance to cocaine abuse therapeutics. Life Sciences, 56, 475-483.
4. Di Paolo, T. (1994). Modulation of brain dopamine transmission by sex steroids. Reviews in the Neurosciences, 5, 27-41.
5. Gottschalk, P. C. H., & Kosten, T. R. (2002). Isradipine enhancement of cerebral blood flow in abstinent cocaine abusers with and without chronic perfusion deficits. American Journal on Addictions, 11, 200-208.
6. Griffiths, R. R., Rush, C. R., & Puhala, K. A. (1996). Validation of the multiple-choice procedure for investigating drug reinforcement in humans. Experimental and Clinical Psychopharmacology, 4, 97-106.
7. Griffiths, R. R., Troisi, J. R., Silverman, K., & Mumford, G. K. (1993). Multiple-choice procedure: An efficient approach for investigating drug reinforcement in humans. Behavioural Pharmacology, 4, 3-13.
8. Haertzen, C. A., Hill, H. E., & Belleville, R. E. (1963). Development of the Addiction Research Center Inventory (ARCI): Selection of items that are sensitive to the effects of various drugs. Psychopharmacologia, 4, 155-166.
9. Holmes, D. G., & Kutz, K. (1993). Bioequivalence of a slow-release and a non-retard formulation of isradipine. American Journal of Hypertension, 6 (3 Pt 2), 70S-73S.
10. Johnson, B., Barron, B., Fang, B., Lamki, L., Wagner, L., Wells, L., et al. (1998). Isradipine prevents global and regional cocaine-induced changes in brain blood flow: A preliminary study. Psychopharmacology, 136, 335-341.
11. Johnson, B., Wells, L., Kenny, P., Abramson, D., Chen, R., Dhother, S., et al. (1999). Effects of isradipine on intravenous cocaine-induced cardiovascular response: A pilot study. Human Psychopharmacology: Clinical and Experimental, 14, 37-43.
12. Johnson, B. A., Devous, M. D., Sr., Ruiz, P., & Ait-Daoud, N. (2001). Treatment advances for cocaine-induced ischemic stroke: Focus on dihydropyridine-class calcium channel antagonists. American Journal of Psychiatry, 158, 1191-1198.
13. Johnson, B. A., Roache, J. D., Ait-Daoud, N., Wells, L. T., & Mauldin, J. B. (2004). Effects of isradipine on cocaine-induced subjective mood. Journal of Clinical Psychopharmacology, 24, 180-191.
14. Johnson, B. A., Wells, L. T., Roache, J. D., Wallace, C., Ait-Daoud, N., & Wang, Y. (in press). Isradipine decreases the hemodynamic response of cocaine and methamphetamine: Results from two human laboratory studies, American Journal of Hypertension.
15. King, T. S., Steger, R. W., & Morgan, W. W. (1986). Effect of ovarian steroids to stimulate region-specific hypothalamic 5-hydroxytryptamine synthesis in ovariectomized rats. Neuroendocrinology, 42, 344-350.
16. Kosten, T. R., Woods, S. W., Rosen, M. I., & Pearsall, H. R. (1999). Interactions of cocaine with nimodipine: A brief report. The American Journal on Addictions, 8, 77-81.
17. Kuzmin, A., Zvartau, E., Gessa, G. L., Martellotta, M. C., & Fratta, W. (1992). Calcium antagonists isradipine and nimodipine suppress cocaine and morphine intravenous self-administration in drug-naive mice. Pharmacology, Biochemistry, and Behavior, 41, 497-500.
18. Malcolm, R., Brady, K. T., Moore, J., & Kajdasz, D. (1999). Amlodipine treatment of cocaine dependence. Journal of Psychoactive Drugs, 31, 117-120.
19. Martellotta, M. C., Kuzmin, A., Muglia, P., Gessa, G. L., & Fratta, W. (1994). Effects of the calcium antagonist isradipine on cocaine intravenous self-adminislration in rats. Psychopharmacology, 113, 378-380.
20. Martin, W. R., Sloan, J. W., Sapira, J. D., & Jasinski, D. R. (1971). Physiologic, subjective, and behavioral effects of amphetamine, methamphetamine, ephedrine, phenmetrazine, and methylphenidate in man. Clinical Pharmacology and Therapeutics, 12, 245-258.
21. Muntaner, C., Kumor, K. M., Nagoshi, C., & Jaffe, J. H. (1991). Effects of nifedipine pretreatment on subjective and cardiovascular responses to intravenous cocaine in humans. Psychopharmacology. 105, 37-41.
22. Pani, L., Kuzmin, A., Diana, M., De Montis, G., Gessa, G. L., & Rossetti, Z. L. (1990). Calcium receptor antagonists modify cocaine effects in the central nervous system differently. European Journal of Pharmacology, 190, 217-221.
23. PDR staff. (2002). Physicians' desk reference. Montvale, NJ: Medical Economics.
24. Pearlson, G. D., Jeffery, P. J., Harris, G. J., Ross, C. A., Fischman, M. W., & Camargo, E. E. (1993). Correlation of acute cocaine-induced changes in local cerebral blood flow with subjective effects. American Journal of Psychiatry, 150, 495-497.
25. Rowbotham, M. C., Hooker. W. D., Mendelson, J., & Jones, R. T. (1987). Cocaine-calcium channel antagonist interactions. Psychopharmacology. 93, 152-154.
26. SAS Institute Inc. (1999). SAS/STAT user's guide, version 8.2. Cary, NC: SAS Institute Inc.
27. Schechter, M. D. (1993). Cocaine discrimination is attenuated by isradipine and CGS 10746B. Pharmacology, Biochemistry, and Behavior, 44, 661-664.
28. Schindler, C. W., Tella, S. R., Prada, J., & Goldberg, S. R. (1995). Calcium channel blockers antagonize some of cocaine's cardiovascular effects, but fail to alter cocaine's behavioral effects. The Journal of Pharmacology and Experimental Therapeutics, 272, 791-798.
29. Sofuoglu, M., Singha, A., Kosten, T. R., McCance-Katz, F. E., Petrakis, I., & Oliveto, A. (2003). Effects of naltrexone and isradipine, alone or in combination, on cocaine responses in humans. Pharmacology, Biochemisiry, and Behavior, 75, 801-808.
30. Spitzer, R., Williams, J., & Gibbon, M. (1995). Structured Clinical Interview for DSM-IV (SCID). New York: Department of Biometrics Research. New York State Psychiatric Institute.